ESMO consensus guidelines for the management of patients with metastatic colorectal cancer | Annals of Oncology | 2016 | 1.7K |
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial | Lancet Oncology, The | 2016 | 1K |
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study | Journal of Clinical Oncology | 2016 | 867 |
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial | Lancet Oncology, The | 2016 | 716 |
The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNA | Nature | 2016 | 523 |
Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood | New England Journal of Medicine | 2016 | 485 |
Task-free MRI predicts individual differences in brain activity during task performance | Science | 2016 | 432 |
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis | Lancet Infectious Diseases, The | 2016 | 382 |
Identification of tissue-specific cell death using methylation patterns of circulating DNA | Proceedings of the National Academy of Sciences of the United States of America | 2016 | 350 |
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study | Lancet Oncology, The | 2016 | 314 |
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial | Lancet Oncology, The | 2016 | 296 |
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually | Bone Marrow Transplantation | 2016 | 265 |
EULAR recommendations for the management of familial Mediterranean fever | Annals of the Rheumatic Diseases | 2016 | 241 |
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation | Bone Marrow Transplantation | 2016 | 224 |
Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening | Annals of Oncology | 2016 | 202 |
Exploring the genetic basis of early-onset chronic kidney disease | Nature Reviews Nephrology | 2016 | 190 |
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy | Gynecologic Oncology | 2016 | 188 |
Extracellular vesicles: roles in gamete maturation, fertilization and embryo implantation | Human Reproduction Update | 2016 | 170 |
Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response | Gastroenterology | 2016 | 166 |
Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure | European Heart Journal | 2016 | 163 |
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice | Cancer Cell | 2016 | 154 |
Less invasive hemodynamic monitoring in critically ill patients | Intensive Care Medicine | 2016 | 149 |
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia | Journal of the American Society of Nephrology: JASN | 2016 | 147 |
Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study | JAMA Internal Medicine | 2016 | 147 |
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry | Autoimmunity Reviews | 2016 | 147 |